Protara Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $38.4M | $36.4M |
| FY2017 | — | $34.7M | $21.2M |
| FY2018 | — | $4.8M | $19.4M |
| FY2019 | — | $-2.1M | $564.0K |
| FY2020 | — | $199.2M | $168.6M |
| FY2021 | — | $161.9M | $35.7M |
| FY2022 | — | $102.1M | $24.1M |
| FY2023 | — | $68.3M | $39.6M |
| FY2024 | — | $167.1M | $162.8M |
| FY2025 | — | $196.4M | $49.7M |